|
|
| |
|
| |
| DENTAVAX 36 mg |
| |
| Composition: |
|
| Each
tablet DENTAVAX contains 36.0 mg freeze-dried lysate and
killed bacterial bodies of the following microbial species:
Lactobacillus acidophilus
Streptococcus pyogenes,
Staphylococcus aureus,
Klebsiella pneumoniae,
Candida albicans. |
Indications: |
| DENTAVAX
has a prophylactic and therapeutic action in case of inflammatory
and infectious diseases of the oral cavity and parodonte:
- gingivitis erythematosa and ulcerosa;
- superficial or profound parodontosis;
- stomatitis, glostitis, aphtae, etc.;
- before and after tonsillectomies and after dental extractions;
- ulcerations and secondary infections caused by artificial
dentures |
Dosage and administration: |
| Tablets for oral administration, which are left to dissolve in the
mouth by sucking. In case of chronic inflammation – 4-6
tablets daily during 15-30 days.
Depending on the clinical data the treatment can be carried
out 2-3 times per year. |
Attention: |
|
Eating and drinking are not allowed for one hour after the
preparation has been taken in order not to disturb its local
effect. |
|
Storage:
|
| It should be stored in the dark, at temperatures below 25°C, out
of reach of children. |
Medicinal dose form and package: |
| 40 tablets of 36 mg in plastic
bottle with screw cap. |
|
Shelf life:
|
| 36
months from the date of manufacture. Do not use the medicinal
preparation after the date of expiry, indicated on the package. |
|
Name and address of manufacturer:
|
BB-NCIPD
Ltd. BULGARIA
1504 Sofia, 26 Yanko Sakazov Blvd.
Tel.: **359 2 944 61 91
Fax:
**359 2 943 30 75
E-mail:
bulbio@bulbio.com
|
| Last Revision: July, 2006 |
|
|
|
|
:Bul Bio: ©2003-2004. All rights reserved.
|